Recurrent focal segmental glomerulosclerosis: A discrete clinical entity

International Journal of Nephrology

Volumn 2012, Issue , 2012, Pages

  Torban, Elena ^a   Bitzan, Martin ^a   Goodyer, Paul ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866235317     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2012/246128     Document Type: Review

References (57)

1. Ernould S., Godron A., Nelson J. -R., Rigothier C., Llanas B., Harambat J., jerome.harambat@chu-bordeaux.fr Idiopathic nephrotic syndrome in children: incidence, clinical presentation, and outcome in the county of Gironde, France. Archives de Pediatrie 2011 18 5 522 528 10.1016/j.arcped.2011.02.012
2. Gbadegesin R., Hinkes B., Vlangos C., Mucha B., Liu J., Hopcian J., Hildebrandt F., Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome. Pediatric Nephrology 2007 22 4 509 513 2-s2.0-33847397014 10.1007/s00467-006-0377-y (Pubitemid 46332328)
3. Tejani A., Phadke K., Nicastri A., Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions. Nephron 1985 41 2 170 173 2-s2.0-0021934186 (Pubitemid 15226358)
4. Churg J., Duffy J. L., Classification of glomerulonephritis based on morphology. Perspectives in Nephrology and Hypertension 1973 1 43 61 2-s2.0-0015689601
5. Tejani A., Morphological transition in minimal change nephrotic syndrome. Nephron 1985 39 3 157 159 2-s2.0-0022001334 (Pubitemid 15152592)
6. Fakhouri F., fakhouri@necker.fr Bocquet N., Taupin P., Presne C., Gagnadoux M. -F., Landais P., Lesavre P., Chauveau D., Knebelmann B., Broyer M., Grünfeld J. -P., Niaudet P., Steroid-sensitive nephrotic syndrome: from childhood to adulthood. American Journal of Kidney Diseases 2003 41 3 550 557 10.1053/ajkd.2003.50116 (Pubitemid 36278371)
7. Schwaderer P., Knüppel T., Konrad M., Mehls O., Schärer K., Schaefer F., Weber S., Clinical course and NPHS2 analysis in patients with late steroid-resistant nephrotic syndrome. Pediatric Nephrology 2008 23 2 251 256 2-s2.0-38349054866 10.1007/s00467-007-0653-5
8. Kyrieleis H. A. C., Löwik M. M., Pronk I., Cruysberg H. R. M., Kremer J. A. M., Oyen W. J. G., Van Den Heuvel B. L. P., Wetzels J. F. M., Levtchenko E. N., Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children. Clinical Journal of the American Society of Nephrology 2009 4 10 1593 1600 2-s2.0-73349103775 10.2215/CJN.05691108
9. Sümegi V., Haszon I., Bereczki C., Papp F., Túri S., Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome. Pediatric Nephrology 2008 23 7 1085 1092 2-s2.0-44449137870 10.1007/s00467-008-0771-8
10. Stadermann M. B., Lilien M. R., van de Kar N. C. A. J., Monnens L. A. H., Schröder C. H., Is biopsy required prior to cyclophosphamide in steroid-sensitive nephrotic syndrome? Clinical Nephrology 2003 60 5 315 317 2-s2.0-0242521658 (Pubitemid 37407688)
11. Niaudet P., Lipoid nephrosis in childhood. Revue du Praticien 2003 53 18 2027 2032 2-s2.0-0347513046 (Pubitemid 38017094)
12. RICH A. R., A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bulletin of the Johns Hopkins Hospital 1957 100 4 173 186 2-s2.0-0000049444
13. Hoyer J. R., Vernier R. L., Najarian J. S., Raij L., Simmons R. L., Michael A. F., Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 1972 2 7773 343 348 2-s2.0-0015516194
14. Jungraithmayr T. C., therese.jungraithmayr@uki.at Hofer K., Cochat P., Chernin G., Cortina G., Fargue S., Grimm P., Knueppel T., Kowarsch A., Neuhaus T., Pagel P., Pfeiffer K. P., Schäfer F., Schönermarck U., Seeman T., Toenshoff B., Weber S., Winn M. P., Zschocke J., Zimmerhackl L. B., Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation. Journal of the American Society of Nephrology 2011 22 3 579 585 10.1681/ASN.2010010029
15. Monteiro E. J. B., Pereira A. C., Pereira A. B., Krieger J. E., Mastroianni-Kirsztajn G., NPHS2 mutations in adult patients with primary focal segmental glomerulosclerosis. Journal of Nephrology 2006 19 3 366 371 2-s2.0-33749077324 (Pubitemid 46785551)
16. He N., Zahirieh A., Mei Y., Lee B., Senthilnathan S., Wong B., Mucha B., Hildebrandt F., Cole D. E., Cattran D., Pei Y., Recessive NPHS2 (Podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosis. Clinical Journal of the American Society of Nephrology 2007 2 1 31 37 2-s2.0-34547845601 10.2215/CJN.02690806
17. Canaud G., guillaume.canaud@nck.aphp.fr Dion D., Zuber J., Gubler M. -C., Sberro R., Thervet E., Snanoudj R., Charbit M., Salomon R., Martinez F., Legendre C., Noel L. -H., Niaudet P., Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS). Nephrology Dialysis Transplantation 2010 25 4 1321 1328 10.1093/ndt/gfp500
18. D'Agati V. D., Fogo A. B., Bruijn J. A., Jennette J. C., Pathologic classification of focal segmental glomerulosclerosis: a working proposal. American Journal of Kidney Diseases 2004 43 2 368 382 10.1053/j.ajkd.2003.10.024 (Pubitemid 38146337)
19. Ijpelaar D. H. T., Farris A. B., Goemaere N., Amann K., Goldschmeding R., Nguyen T. Q., Farkash E., Van Den Heuvel M. C., De Heer E., Bruijn J. A., Colvin R. B., Bajema I. M., Fidelity and evolution of recurrent FSGS in renal allografts. Journal of the American Society of Nephrology 2008 19 11 2219 2224 2-s2.0-55749105293 10.1681/ASN.2007121365
20. Coward R. J. M., Foster R. R., Patton D., Ni L., Lennon R., Bates D. O., Harper S. J., Mathieson P. W., Saleem M. A., Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes. Journal of the American Society of Nephrology 2005 16 3 629 637 2-s2.0-20544465220 10.1681/ASN.2004030172 (Pubitemid 41725099)
21. Sharma R., Sharma M., McCarthy E. T., Ge X. L., Savin V. J., Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro. Kidney International 2000 58 5 1973 1979 2-s2.0-0033753068 10.1046/j.1523-1755.2000.00369.x
22. Canaud G., guillaume.canaud@nck.aphp.fr Zuber J., Sberro R., Royale V., Anglicheau D., Snanoudj R., Gaha K., Thervet E., Lefrère F., Cavazzana-Calvo M., Noël L. -H., Méjean A., Legendre Ch., Martinez F., Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study. American Journal of Transplantation 2009 9 5 1081 1086 10.1111/j.1600-6143.2009.02580.x
23. Lagrue G., Branellec A., Niaudet P., Heslan J. M., Guillot F., Lang P., Transmission of nephrotic syndrome to two neonates. Spontaneous regression. Presse Medicale 1991 20 6 255 257 2-s2.0-0025921378
24. Orman S. V., Schechter G. P., Whang-Peng J., Nephrotic syndrome associated with a clonal T-cell leukemia of large granular lymphocytes with cytotoxic function. Archives of Internal Medicine 1986 146 9 1827 1829 2-s2.0-0022475762 (Pubitemid 16018931)
25. Le Berre L., Bruneau S., Naulet J., Renaudin K., Buzelin F., Usal C., Smit H., Condamine T., Soulillou J. P., Dantal J., Induction of T regulatory cells attenuates idiopathic nephrotic syndrome. Journal of the American Society of Nephrology 2009 20 1 57 67 2-s2.0-58149489323 10.1681/ASN.2007111244
26. Bao L., Brad Spiller O., St. John P.L. P. L., Haas M., Hack B. K., Ren G., Cunningham P. N., Doshi M., Abrahamson D. R., Morgan B. P., Quigg R. J., Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytes. Kidney International 2002 62 6 2010 2021 2-s2.0-18744378822 10.1046/j.1523-1755.2002.t01-1-00652.x (Pubitemid 35366155)
27. Benz K., Dötsch J., Rascher W., Stachel D., Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatric Nephrology 2004 19 7 794 797 2-s2.0-19244365794 10.1007/s00467-004-1434-z (Pubitemid 38931165)
28. Gilbert R. D., Hulse E., Rigden S., Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediatric Nephrology 2006 21 11 1698 1700 2-s2.0-33748704524 10.1007/s00467-006-0228-x (Pubitemid 44390835)
29. Pescovitz M. D., Book B. K., Sidner R. A., Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. New England Journal of Medicine 2006 354 18 1961 1963 2-s2.0-33646347166 10.1056/NEJMc055495 (Pubitemid 43872718)
30. Bagga A., Sinha A., Moudgil A., Rituximab in patients with the steroid-resistant nephrotic syndrome. New England Journal of Medicine 2007 356 26 2751 2752 2-s2.0-34347250137 10.1056/NEJMc063706 (Pubitemid 47001064)
31. McCarthy E. T., Sharma M., Sharma R., Falk R. J., Jennette J. C., Sera from patients with collapsing focal segmental glomerulosclerosis increase albumin permeability of isolated glomeruli. Journal of Laboratory and Clinical Medicine 2004 143 4 225 229 2-s2.0-1942536121 10.1016/j.lab.2004.01.007 (Pubitemid 38510118)
32. Savin V. J., McCarthy E. T., Sharma R., Charba D., Sharma M., Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity. Translational Research 2008 151 6 288 292 2-s2.0-50949086886 10.1016/j.trsl.2008.04.001
33. Wei C., El Hindi S., Li J., Fornoni A., Goes N., Sageshima J., Maiguel D., Karumanchi S. A., Yap H. -K., Saleem M., Zhang Q., Nikolic B., Chaudhuri A., Daftarian P., Salido E., Torres A., Salifu M., Sarwal M. M., Schaefer F., Morath C., Schwenger V., Zeier M., Gupta V., Roth D., Rastaldi M. P., Burke G., Ruiz P., Reiser J., jreiser@med.miami.edu Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nature Medicine 2011 17 8 952 960 10.1038/nm.2411
34. Bifulco K., kbifulco@libero.it Carriero M. V., mariolinacarriero@yahoo.it Longanesi-Cattani I., immalonganesi@libero.it Masucci M. T., mtmasucci@libero.it De Chiara A., annadechiara@hotmail.com Fazioli F., fazioli@unina.it Di Carluccio G., dicarluccio.gioconda@libero.it Pirozzi G., pinopirozzi@libero.it Gallo M., miga76@alice.it La Rocca A., alarocca@libero.it Apice G., gaetanoapice@virgilio.it Rocco G., Gaetano.Rocco@btopenworld.com Involvement of the soluble urokinase receptor in chondrosarcoma cell mobilization. Sarcoma 2011 2011 10 10.1155/2011/842842 842842
35. Leroy S., Guigonis V., Bruckner D., Emal-Aglae V., Deschênes G., Bensman A., Ulinski T., tim.ulinski@trs.aphp.fr Successful anti-TNF α treatment in a child with posttransplant recurrent focal segmental glomerulosclerosis. American Journal of Transplantation 2009 9 4 858 861 10.1111/j.1600-6143.2009.02550.x
36. Bakr A., Shokeir M., El-Chenawi F., El-Husseni F., Abdel-Rahman A., El-Ashry R., Tumor necrosis factor- α production from mononuclear cells in nephrotic syndrome. Pediatric Nephrology 2003 18 6 516 520 2-s2.0-0038159498 (Pubitemid 36790090)
37. Assadi F., Neonatal nephrotic syndrome associated with placental transmission of proinflammatory cytokines. Pediatric Nephrology 2010 26 3 1 3 2-s2.0-78649328806 10.1007/s00467-010-1700-1
38. Bruggeman L. A., leslie.bruggeman@case.edu Drawz P. E., Kahoud N., Lin K., Barisoni L., Nelson P. J., TNFR2 interposes the proliferative and NF-B-mediated inflammatory response by podocytes to TNF- α Laboratory Investigation 2011 91 3 413 425 10.1038/labinvest.2010.199
39. Doublier S., Musante L., Lupia E., Candiano G., Spatola T., Caridi G., Zennaro C., Carraro M., Ghiggeri G. M., Camussi G., Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes. International Journal of Molecular Medicine 2005 16 1 49 58 2-s2.0-33644649790
40. Babayeva S., Zilber Y., Torban E., elena.torban@mcgill.ca Planar cell polarity pathway regulates actin rearrangement, cell shape, motility, and nephrin distribution in podocytes. American Journal of Physiology. Renal Physiology 2011 300 2 F549 F560 10.1152/ajprenal.00566.2009
41. Babayeva S., Miller M., Zilber Y., Kares R. E., Bernard C., Bitzan M., Goodyer P., Torban E., elena.torban@mcgill.ca Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytes. Pediatric Nephrology 2011 26 7 1071 1081 10.1007/s00467-011-1831-z
42. Noël L. H., Morphological features of primary focal and segmental glomerulosclerosis. Nephrology Dialysis Transplantation 1999 14 supplement 3 53 57 10.1093/ndt/14.suppl3.53 (Pubitemid 29241713)
43. Nakamura T., Ushiyama C., Suzuki S., Hara M., Shimada N., Ebihara I., Koide H., The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome. American Journal of Nephrology 2000 20 3 175 179 2-s2.0-0033921768 (Pubitemid 30445310)
44. Chen C. A., Hwang J. C., Guh J. Y., Chang J. M., Lai Y. H., Chen H. C., Reduced podocyte expression of α 3 β 1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats. Journal of Laboratory and Clinical Medicine 2006 147 2 74 82 2-s2.0-31944440132 10.1016/j.lab.2005.08.011 (Pubitemid 43188999)
45. Kriz W., Hosser H., Hähnel B., Gretz N., Provoost A. P., From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: a histopathological study in rat models and human gomerulopathies. Nephrology Dialysis Transplantation 1998 13 11 2781 2798 2-s2.0-0031756766 10.1093/ndt/13.11.2781 (Pubitemid 28479524)
46. Dijkman H., Smeets B., Van Der Laak J., Steenbergen E., Wetzels J., The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis. Kidney International 2005 68 4 1562 1572 2-s2.0-30944439368 10.1111/j.1523-1755.2005.00568.x (Pubitemid 43169901)
47. Achenbach J., Mengel M., Tossidou I., Peters I., Park J. -K., Haubitz M., Ehrich J. H., Haller H., Schiffer M., schiffer.mario@mh-hannover.de Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases. Nephrology Dialysis Transplantation 2008 23 10 3138 3145 10.1093/ndt/gfn235
48. Bariéty J., Bruneval P., Hill G., Irinopoulou T., Mandet C., Meyrier A., Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation. Journal of the American Society of Nephrology 2001 12 2 261 274 2-s2.0-0035140452 (Pubitemid 32116368)
49. Smeets B., Kuppe C., Sicking E. -M., Fuss A., Jirak P., Van Kuppevelt T. H., Endlich K., Wetzels J. F.M., Gröne H. -J., Floege J., Moeller M. J., mmoeller@ukaachen.de Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. Journal of the American Society of Nephrology 2011 22 7 1262 1274 10.1681/ASN.2010090970
50. Ulinski T., Recurrence of focal segmental glomerulosclerosis after kidney transplantation: strategies and outcome. Current Opinion in Organ Transplantation 2010 15 5 628 632 2-s2.0-77957600499 10.1097/MOT. 0b013e32833dee3a
51. Vinai M., Waber P., Seikaly M. G., Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review. Pediatric Transplantation 2010 14 3 314 325 2-s2.0-77950650794 10.1111/j.1399-3046.2009. 01261.x
52. Salomon R., Gagnadoux M. F., Niaudet P., Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 2003 75 6 810 814 2-s2.0-0037468696 10.1097/01.TP.0000055215. 20367.21 (Pubitemid 36373453)
53. Dall'Amico R., Ghiggeri G., Carraro M., Artero M., Ghio L., Zamorani E., Zennaro C., Basile G., Montini G., Rivabella L., Cardillo M., Scalamogna M., Ginevri F., Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. American Journal of Kidney Diseases 1999 34 6 1048 1055 2-s2.0-0032722211
54. Strologo L. D., Guzzo I., Laurenzi C., Vivarelli M., Parodi A., Barbano G., Camilla R., Scozzola F., Amore A., Ginevri F., Murer L., Use of rituximab in focal glomerulosclerosis relapses after renal transplantation. Transplantation 2009 88 3 417 420 2-s2.0-69449108619 10.1097/TP.0b013e3181aed9d7
55. Kaito H., Kamei K., Kikuchi E., Ogura M., Matsuoka K., Nagata M., Iijima K., Ito S., Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin. Pediatric Nephrology 2010 25 5 957 959 2-s2.0-77951254454 10.1007/s00467-009- 1410-8
56. Sethna C., Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab. Journal of Transplantation 2011 2011 5 10.1155/2011/389542 389542
57. Fornoni A., afornoni@med.miami.edu Sageshima J., Wei C., Merscher-Gomez S., Aguillon-Prada R., Jauregui A. N., Li J., Mattiazzi A., Ciancio G., Chen L., Zilleruelo G., Abitbol C., Chandar J., Seeherunvong W., Ricordi C., Ikehata M., Rastaldi M. P., Reiser J., jreiser@med.miami.edu Burke III G. W., gburke@med.miami.edu Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Science Translational Medicine 2011 3 85 10.1126/scitranslmed.3002231 85ra46